Photo: Photo: Portra/Getty Images
CustoMED, an orthopedic platform, has closed a $6 million seed round, bringing its total funding to $6 million.
Longevity Venture Partners, Varana Capital, Flag Capital, the Israel Innovation Authority and Avishai Abrahami, cofounder and CEO of Wix, participated in the round.
WHAT IT DOES
CustoMED's cloud-based platform merges AI and automation with 3D printing to generate surgical tools and implants straight from a surgeon's pre-operative plan.
According to the company, the patient-specific devices are built onsite or via certified partners and integrate into existing surgical workflows, allowing less intraoperative errors and more predictable outcomes.
CustoMED emanates from Tel HaShomer, Israel-based Sheba Medical Center's 3D Printing and Innovation Lab.
The funds will be used to speed up CustoMED's growth into new automated orthopedic indications, support U.S. and European Union regulatory milestones with approvals anticipated for 2026 and deploy its manufacturing model.
"CustoMED's patient-specific surgical tools enable more precise orthopedic surgeries through affordable, real-time solutions delivered directly into the operating room," Or Benifla, cofounder of CustoMED, said in a statement.
"By putting scalable, personalized technology directly in surgeons' hands, our mission is to make computer-guided surgery fast, accessible and routine, transforming what was once a boutique process into standard of care for every patient."
MARKET SNAPSHOT
Other companies in the 3D printing space include Pete Pharma, which in September partnered with Fabrx to bring the company's pharmaceutical 3D printing technology to the compounding pharmacy market in the U.S.
Fabrx's pharmaceutical 3D printing platform is used in hospitals, universities and clinical research centers.
According to the company, the M3DIMAKER 1 is Fabrx's single printhead pharmaceutical 3D printer used for research and small-batch manufacture of personalized medicine and medical devices.
In April, 3D printed orthopedic implant care company restor3d raised $38 million. The company markets joint replacements and 3D printing of osseointegrative materials, AI-based planning and design automation tools.
The funding was used to launch four new 3D printed product lines.
According to the National Institutes of Health (NIH), three-dimensional printing has quickly become an evolutionary force in orthopedic surgery, allowing the creation of highly individualized and accurate medical implants and surgical tools.
Lattice Medical is a company offering 3D printed breast implants for women who have undergone a mastectomy.
In June, Julie Payen, cofounder and CEO of Lattice Medical, joined MobiHealthNews as part of its Emerging Technologies series to discuss the company's 3D-printed, resorbable breast implant that uses a patient's own fat to regenerate natural breast tissue following a mastectomy.
